FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
Read more: FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism
Pages
▼
Wednesday, October 31, 2018
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use
Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use
Tuesday, October 30, 2018
US FDA News: FDA takes action to stop the use of lead acetate in hair dyes
FDA takes action to stop the use of lead acetate in hair dyes. FDA will no longer allow lead acetate to be used in certain hair coloring products based on data that demonstrate that there is no longer a reasonable certainty of no harm from the use of this color additive.
Read more: FDA takes action to stop the use of lead acetate in hair dyes
Read more: FDA takes action to stop the use of lead acetate in hair dyes
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation
FDA announces new plan to advance the development of plant and animal biotechnology innovation
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., and Deputy Commissioner Anna Abram on the FDA’s new plan to advance plant, animal biotechnology innovation
Monday, October 29, 2018
Pharma Reviews: India to create a vibrant startup eco-system and Russia will actively partner in setting up incubation ...
Commerce Minister said that Russia can be a valuable market in ... India's pharma exports to Russia constitute a sizable chunk but possibilities of joint ...
Read more: India to create a vibrant startup eco-system and Russia will actively partner in setting up incubation ...
Read more: India to create a vibrant startup eco-system and Russia will actively partner in setting up incubation ...
Pharma Reviews: Shaily Engineering Plastics: Investment-worthy at current levels
The company's clientele includes some of the world's most well-known ... After seeking approvals from a US-based medical company, Shaily aims to earn ... low due to slower-than-anticipated demand from Indian pharma companies.
Read more: Shaily Engineering Plastics: Investment-worthy at current levels
Read more: Shaily Engineering Plastics: Investment-worthy at current levels
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies
Food allergies have touched the lives of most of us. Thousands of Americans experience life-threatening, food-related reactions each year, and an estimated 20 people die from them annually. In some cases, such reactions occur despite a careful reading of packaged food labels by conscientious consumers. To me, that’s unacceptable. The FDA is committed to advancing our efforts to help ensure that Americans have access to the information they need about common allergens in packaged foods.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new consideration of labeling for sesame allergies
Sunday, October 28, 2018
Pharma Reviews: The digital supply chain is not just about compliance; it's also about business value and optimization.
While the Indian government requires Indian pharmaceutical companies to comply with the Drug Authentication Verification Application (DAVA) ...
Read more: The digital supply chain is not just about compliance; it's also about business value and optimization.
Read more: The digital supply chain is not just about compliance; it's also about business value and optimization.
Pharma Reviews: Laminated Pills
The Indian pharma industry is commendable, in being able to supply medication (though most be branded generics) to the vast population of this ...
Read more: Laminated Pills
Read more: Laminated Pills
Pharma Reviews: Big pharma cos set to return to double-digit growth this fiscal: Crisil
Big pharma cos set to return to double-digit growth this fiscal: Crisil ... After two consecutive years of single-digit expansion, big Indian drug firms ... listed drug-makers, which account for three-fourths of the pharma industry revenue.
Read more: Big pharma cos set to return to double-digit growth this fiscal: Crisil
Read more: Big pharma cos set to return to double-digit growth this fiscal: Crisil
Pharma Reviews: Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil
Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil ... After two consecutive years of single-digit expansion, big Indian drug firms are ... listed drugmakers, which account for three-fourths of the pharma industry revenue.
Read more: Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil
Read more: Big Pharma Firms To Grow In Double Digits In FY19, Says Crisil
Pharma Reviews: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL
The return to double-digit growth would help the homegrown pharma companies, with turnover of Rs 10 billion or more, to weather a sharp rise in ...
Read more: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL
Read more: Indian pharma to hit double-digit growth on US sales, weak rupee: CRISIL
Pharma Reviews: Crisil says Indian pharma companies will witness strong growth this fiscal
After two consecutive years of single-digit expansion, big Indian drug firms are expected to return to double-digit growth in the current fiscal aided by a ...
Read more: Crisil says Indian pharma companies will witness strong growth this fiscal
Read more: Crisil says Indian pharma companies will witness strong growth this fiscal
Pharma Reviews: Big pharma companies set to return to double-digit growth this fiscal: Crisil
NEW DELHI: After two consecutive years of single-digit expansion, big Indian drug firms are expected to return to double-digit growth in the current ...
Read more: Big pharma companies set to return to double-digit growth this fiscal: Crisil
Read more: Big pharma companies set to return to double-digit growth this fiscal: Crisil
Saturday, October 27, 2018
Pharma Reviews: A case for branded generics
Making a mark in the global market, India is the largest provider of generic drugs globally. Today, the Indian pharmaceutical sector industry supplies ...
Read more: A case for branded generics
Read more: A case for branded generics
Pharma Reviews: Bitter pill
According to some estimates, the Indian drug market has over 70,000 formulations, created from a basic number of around 750 active pharmaceutical ...
Read more: Bitter pill
Read more: Bitter pill
Pharma Reviews: Professor Bhupinder Singh to be conferred with pharma fellowship award
Panjab University's Professor Bhupinder Singh Bhoop has been selected for prestigious "Fellowship Award of the Indian Pharmaceutical Association ...
Read more: Professor Bhupinder Singh to be conferred with pharma fellowship award
Read more: Professor Bhupinder Singh to be conferred with pharma fellowship award
Pharma Reviews: PU professor to be conferred with prestigious pharma fellowship award
... "Fellowship Award of the Indian Pharmaceutical Association (ÌPA)" for the ... Sciences (2014-17), Dean, Faculty of Pharmaceutical Sciences, Panjab ...
Read more: PU professor to be conferred with prestigious pharma fellowship award
Read more: PU professor to be conferred with prestigious pharma fellowship award
Pharma Reviews: 'Banned ingredients in diet pills putting Indians at risk'
Often to circumvent drug price regulation or stringent pharmaceutical norms, companies tweak their pharma formulations and launch their products as ...
Read more: 'Banned ingredients in diet pills putting Indians at risk'
Read more: 'Banned ingredients in diet pills putting Indians at risk'
Wednesday, October 24, 2018
US FDA News: FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
Read more: FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
Read more: FDA permits marketing of a diagnostic test to aid in the determination of menopausal status
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
The SUPPORT Act grants FDA additional authorities to meaningfully advance efforts to combat the crisis of opioid addiction plaguing our nation.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on how new regulatory authorities will assist the agency in more forcefully addressing opioid crisis; included as part of the newly enacted Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act
US FDA News: FDA approves new drug to treat influenza
FDA approved Xofluza (baloxavir marboxil) to treat acute uncomplicated flu in patients 12 years old and older who have been symptomatic for less than 48 hours.
Read more: FDA approves new drug to treat influenza
Read more: FDA approves new drug to treat influenza
Tuesday, October 23, 2018
Pharma Reviews: Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday
Zydus Cadila is the country's fourth-largest Indian pharmaceutical company with ... The original plan was to sell only the Indian operations and brands.
Read more: Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday
Read more: Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on Wednesday
Pharma Reviews: Indian pharma industry to grow at 7-9 pct between 2018-21: Report
Indian companies have gained adequate scale and drug development capabilities over the last decade of growth.
Read more: Indian pharma industry to grow at 7-9 pct between 2018-21: Report
Read more: Indian pharma industry to grow at 7-9 pct between 2018-21: Report
Pharma Reviews: Pharma sector to post moderate 7-9% CAGR due to healthy demand
Indian companies have gained adequate scale and drug development capabilities over last decade of growth which will keep them in good stead to ...
Read more: Pharma sector to post moderate 7-9% CAGR due to healthy demand
Read more: Pharma sector to post moderate 7-9% CAGR due to healthy demand
Pharma Reviews: Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21
The growth trajectory for the Indian pharmaceutical industry is likely to be moderate at 7-9% over FY2018 to FY2021, on the back of healthy demand ...
Read more: Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21
Read more: Pharma sector growth to moderate at 7-9% CAGR for FY 2018-21
US FDA News: Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer
A federal court orders a Tennessee-based company to stop selling over-the-counter (OTC) drug products
Read more: Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer
Read more: Federal judge enters consent decree against Tennessee over-the-counter drug manufacturer
US FDA News: FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids
FDA warns website networks as part of global crack down for selling illegal pharmaceuticals
Read more: FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids
Read more: FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs; including opioids
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to advance new ways to increase the availability of naloxone as one means for reducing opioid overdose deaths
Monday, October 22, 2018
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death
Pharma Reviews: Gujarat's pharma sector to draw Rs 6-9000 crore investment
This will provide a significant boost to pharma production in the state,” said Viranchi Shah, chairman, Gujarat State Board, Indian Drug Manufacturers' ...
Read more: Gujarat's pharma sector to draw Rs 6-9000 crore investment
Read more: Gujarat's pharma sector to draw Rs 6-9000 crore investment
Friday, October 19, 2018
Pharma Reviews: FII View | Foreign investors cautious on India, pharma & consumption attractive: Steven Birch
Stocks are in good health, the manufacturing facilities of Biocon, Cipla have come clear with USFDA inspection. Indian pharma firms can benefit from ...
Read more: FII View | Foreign investors cautious on India, pharma & consumption attractive: Steven Birch
Read more: FII View | Foreign investors cautious on India, pharma & consumption attractive: Steven Birch
Pharma Reviews: SCHOTT Tubing India to further 20 million euros in India
SCHOTT AG, a global pioneer in manufacturing pharmaceutical glass and packaging, has announced the launch of a new glass tank in its Indian ...
Read more: SCHOTT Tubing India to further 20 million euros in India
Read more: SCHOTT Tubing India to further 20 million euros in India
US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, fresh-cut produce processors more effectively comply with food safety requirements
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements
Thursday, October 18, 2018
US FDA News: Trump Administration Launches “Winning on Reducing Food Waste” Initiative
The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the "Winning on Reducing Food Waste" initiative.
Read more: Trump Administration Launches “Winning on Reducing Food Waste” Initiative
Read more: Trump Administration Launches “Winning on Reducing Food Waste” Initiative
Pharma Reviews: Intellectual Property Policy Can Boost Both Innovation and Access to Medicines
India's policy framework started off by supporting the growth of the domestic pharma industry that espoused reverse-engineering methods to mass ...
Read more: Intellectual Property Policy Can Boost Both Innovation and Access to Medicines
Read more: Intellectual Property Policy Can Boost Both Innovation and Access to Medicines
Pharma Reviews: India: The Sunshine Sector In "Make In India" – Medical Device Industry Shines As Never Before
With the rapidly expanding Indian pharmaceutical and healthcare sector over the years, the growth in demand for advanced and innovative medical ...
Read more: India: The Sunshine Sector In "Make In India" – Medical Device Industry Shines As Never Before
Read more: India: The Sunshine Sector In "Make In India" – Medical Device Industry Shines As Never Before
Tuesday, October 16, 2018
Pharma Reviews: El Salvador eyes Indian investors
El Salvador is keen to attract investments from Indian companies in the energy, ITeS, pharma, manufacturing and textiles sectors, the Central ...
Read more: El Salvador eyes Indian investors
Read more: El Salvador eyes Indian investors
Pharma Reviews: Tycoon Piramal Weighs $1 Billion Contract Pharma Sale
(Bloomberg) -- Indian tycoon Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people ...
Read more: Tycoon Piramal Weighs $1 Billion Contract Pharma Sale
Read more: Tycoon Piramal Weighs $1 Billion Contract Pharma Sale
Pharma Reviews: Insolvency code helps, but investors may turn cautious as election nears
The pharma sector was also active during the quarter, recording eight deals worth $1.3 ... Another deal in the sector was Constellation Alpha Capital Corp's ... marking the largest investment in an Indian diagnostics company till date.
Read more: Insolvency code helps, but investors may turn cautious as election nears
Read more: Insolvency code helps, but investors may turn cautious as election nears
US FDA News: FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agency’s broader effort to protect patient safety
FDA and DHS announce partnership to address medical device cybersecurity threats
Read more: FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agency’s broader effort to protect patient safety
Read more: FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agency’s broader effort to protect patient safety
Monday, October 15, 2018
Pharma Reviews: India & Korea ink MoU to promote Medical Devices Sector
In a bid to further provide an impetus and boost Indian & Korean Medical Device Industry, The Association of Indian Medical Device Industry (AiMeD) ...
Read more: India & Korea ink MoU to promote Medical Devices Sector
Read more: India & Korea ink MoU to promote Medical Devices Sector
Pharma Reviews: Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%
Shares of pharmaceutical were in focus in an otherwise subdued market on ... Natco Pharma, Morepen Laboratories, Granules India and Sequent ...
Read more: Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%
Read more: Pharma shares in focus; Dr Reddy's, Biocon, Lupin, Natco Pharma up over 3%
Pharma Reviews: How technology is evolving healthcare industry, offering a patient-centric experience
Counterfeit drugs are one of the most critical issues prevailing in the Indian pharmaceutical industry that can put the patients at a higher risk. Hence ...
Read more: How technology is evolving healthcare industry, offering a patient-centric experience
Read more: How technology is evolving healthcare industry, offering a patient-centric experience
US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies
FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies
Sunday, October 14, 2018
Pharma Reviews: Pharmaceuticals Q2FY19 preview: Quarter likely to see muted performance
We expect Indian Pharma to report 9% y-o-y revenue growth and 100bps margin drop ... For Sun Pharma, specialty launch spend remains the key. ... for the overall industry (213 in Q2FY19 vs 208 in Q1FY19) and Indian companies.
Read more: Pharmaceuticals Q2FY19 preview: Quarter likely to see muted performance
Read more: Pharmaceuticals Q2FY19 preview: Quarter likely to see muted performance
Saturday, October 13, 2018
Pharma Reviews: Drug makers may have to pay 5 times more for pharma imports
... and get their overseas manufacturing facilities audited by the Indian regulator. The move aims to increase domestic manufacturing of medicines.
Read more: Drug makers may have to pay 5 times more for pharma imports
Read more: Drug makers may have to pay 5 times more for pharma imports
Friday, October 12, 2018
Pharma Reviews: ePHARMACIES' TIME HAS COME
Over the past few years, the Indian pharma sector has been gaining traction largely owing to some of the key regulatory and policy changes that have ...
Read more: ePHARMACIES' TIME HAS COME
Read more: ePHARMACIES' TIME HAS COME
Pharma Reviews: OPPI advocates for policies that promote scientific temperament
The Organisation of Pharmaceutical Producers of India (OPPI) celebrated their 52nd Annual Day recently. Themed #HealthMeetsHope, the Chief ...
Read more: OPPI advocates for policies that promote scientific temperament
Read more: OPPI advocates for policies that promote scientific temperament
Pharma Reviews: Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments
The Indian pharmaceutical market (IPM) grew at 9.7 percent in the second quarter ended September, according to market research firm ...
Read more: Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments
Read more: Indian pharma market grows 9.7% in Q2FY19 on uptake across therapy segments
US FDA News: FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy
FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy
Read more: FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy
Read more: FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy
Thursday, October 11, 2018
US FDA News: FDA approves new DNA-based test to determine blood compatibility
FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results
Read more: FDA approves new DNA-based test to determine blood compatibility
Read more: FDA approves new DNA-based test to determine blood compatibility
Wednesday, October 10, 2018
Pharma Reviews: What changed for the market while you were sleeping? Top 10 things to know
The Dow Jones Industrial Average fell 56.21 points, or 0.21 percent, ... Over-dependence of Indian pharma industry on imported raw materials from ...
Read more: What changed for the market while you were sleeping? Top 10 things to know
Read more: What changed for the market while you were sleeping? Top 10 things to know
Tuesday, October 9, 2018
Pharma Reviews: Govt working on plan to raise API production to cut Chinese dependence: Comm Min report
Over-dependence of Indian pharma industry on imported raw materials from China to meet the growing requirements of drug formulations is a cause ...
Read more: Govt working on plan to raise API production to cut Chinese dependence: Comm Min report
Read more: Govt working on plan to raise API production to cut Chinese dependence: Comm Min report
US FDA News: La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad
La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad
Read more: La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad
Read more: La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines
FDA issued a new series of guidance documents that will advance the development of generic transdermal and topical delivery systems
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines
Monday, October 8, 2018
Pharma Reviews: Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant ...
The mass exodus of fear-gripped North Indian migrant workers from Gujarat, in the wake of threats and attacks, may create problems for the pharma ...
Read more: Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant ...
Read more: Gujarat pharma industry says business as usual, but seeks govt action against attacks on migrant ...
Pharma Reviews: 3-Point Analysis | Will China's crackdown on drug manufacturers impact India?
The Chinese government is cracking down on thousands of pharma factories to check pollution and raise safety standards in the country. While this is ...
Read more: 3-Point Analysis | Will China's crackdown on drug manufacturers impact India?
Read more: 3-Point Analysis | Will China's crackdown on drug manufacturers impact India?
Friday, October 5, 2018
Pharma Reviews: Russia May Increase Oil Production to Stabilise Global Prices After Modi-Putin Meet
Putin also mooted the possibility of a private partnership of Indian entities to explore Arctic gas, the official said. ... On his part, Modi highlighted the IT industry and pharma industry and hope the Russian market will be substantially ...
Read more: Russia May Increase Oil Production to Stabilise Global Prices After Modi-Putin Meet
Read more: Russia May Increase Oil Production to Stabilise Global Prices After Modi-Putin Meet
Pharma Reviews: Pharma, Railways and infrastructure key areas of cooperation between India and Russia
India and Russia welcomed the establishment of a pharmaceutical plant by Advance Pharma Company in Russia. The Indian Side conveyed its ...
Read more: Pharma, Railways and infrastructure key areas of cooperation between India and Russia
Read more: Pharma, Railways and infrastructure key areas of cooperation between India and Russia
Pharma Reviews: Enhancing Affordable Pharmaceutical Healthcare
There are noticeable growth surges, especially in key sectors such as pharmaceuticals (India is frequently referred to as the “global generics capital”), ...
Read more: Enhancing Affordable Pharmaceutical Healthcare
Read more: Enhancing Affordable Pharmaceutical Healthcare
US FDA News: FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
Read more: FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
Read more: FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
US FDA News: FDA allows marketing of first self-fitting hearing aid controlled by the user
FDA allows marketing of a new device, the Bose Hearing Aid, intended to amplify sounds for individuals 18 years or older with perceived mild to moderate hearing impairment (hearing loss). This is the first hearing aid authorized for marketing by the FDA that enables the user to fit, program and control the hearing aid on his or her own, without assistance from a health care provider.
Read more: FDA allows marketing of first self-fitting hearing aid controlled by the user
Read more: FDA allows marketing of first self-fitting hearing aid controlled by the user
Thursday, October 4, 2018
Pharma Reviews: US may dilute norm used to delay generics
(q) of the US Federal Food, Drug and Cosmetic Act to delay the launch of ... But in the last three years quality issues in Indian manufacturing plants ...
Read more: US may dilute norm used to delay generics
Read more: US may dilute norm used to delay generics
Wednesday, October 3, 2018
Pharma Reviews: Pharma Startup Elbrit Life Sciences Raises $3 Mn from Its Parent & Qatar-based Investment Firm
The fast growing domestic pharmaceutical company is presently in ... He added that the company majorly operates in South India and has sales force ...
Read more: Pharma Startup Elbrit Life Sciences Raises $3 Mn from Its Parent & Qatar-based Investment Firm
Read more: Pharma Startup Elbrit Life Sciences Raises $3 Mn from Its Parent & Qatar-based Investment Firm
Pharma Reviews: What next on the Agenda?
India also has one of the highest tariff rates when it comes to pharmaceutical import. India is at the top (or more properly, bottom) five offenders on drug ...
Read more: What next on the Agenda?
Read more: What next on the Agenda?
Tuesday, October 2, 2018
Pharma Reviews: India Must Move Beyond IPR-Protection to Focus on Better Health Outcomes
A lack of a strong IPR regime and drug price control – India is already ... The value of global export in pharmaceutical items has grown from $228 ...
Read more: India Must Move Beyond IPR-Protection to Focus on Better Health Outcomes
Read more: India Must Move Beyond IPR-Protection to Focus on Better Health Outcomes
Pharma Reviews: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix
The problem of fake and counterfeit drugs is a major issue, costing the Indian pharma industry billions of rupees, said Amitabh Kant, CEO, NITI Aayog.
Read more: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix
Read more: Fake medicines: Here's Niti Aayog, Apollo Hospital, Oracle & Pharma sciences blockchain fix
Pharma Reviews: Meet the man giving tough time to Indian IT companies in the US
Kotchen did not start out to lead a crusade against Indian IT companies. ... At the FTC, he was part of investigations into pharmaceutical companies ...
Read more: Meet the man giving tough time to Indian IT companies in the US
Read more: Meet the man giving tough time to Indian IT companies in the US
Pharma Reviews: Daniel Kotchen: Man behind legal threats to Indian IT firewall
If Kotchen wins, not only could he cost Indian outsourcing companies ... At the FTC, he was part of investigations into pharmaceutical companies and ...
Read more: Daniel Kotchen: Man behind legal threats to Indian IT firewall
Read more: Daniel Kotchen: Man behind legal threats to Indian IT firewall
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions
FDA issues revised guidance to allow for a more efficient approach to 505(q) petitions and focus more resources on scientific reviews.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency actions to further deter ‘gaming’ of the generic drug approval process by the use of citizen petitions
Monday, October 1, 2018
Pharma Reviews: China fuels drug fears
A crackdown on environmental pollution by China and inaction by the Indian government on industry pleas to revive the weakened domestic ...
Read more: China fuels drug fears
Read more: China fuels drug fears
Pharma Reviews: Pharma, food processing, textiles under focus to boost Indian exports
The Commerce Ministry is focusing on nine sectors, including pharma, food processing and textiles, to boost exports in the current fiscal, an official ...
Read more: Pharma, food processing, textiles under focus to boost Indian exports
Read more: Pharma, food processing, textiles under focus to boost Indian exports
Pharma Reviews: India-Uzbekistan sign 17 agreements including visa-free travel, military edu
India and Uzbekistan inked 17 agreements on Monday including in military education and visa-free travel for diplomatic passport holders. ... nations agreed to collaborate with each other across sectors with special focus on pharma.
Read more: India-Uzbekistan sign 17 agreements including visa-free travel, military edu
Read more: India-Uzbekistan sign 17 agreements including visa-free travel, military edu
US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients
FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s efforts to strengthen the agency’s medical device cybersecurity program as part of its mission to protect patients